Alland Leila

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$51,799.00
Insider Sells Quantity
9
Insider Sells Sum
$1.16M

Insider Activity of Alland Leila

According to the SEC Form 4 filings, Alland Leila, being in a position of

  1. director at Abeona Therapeutics Inc.,
    оver the last 12 months, has bought 11000 shares for $51,799, and sold 0 shares,
    over all time since 2023-09-27, has bought 11000 shares for $51,799, and sold 7246 shares for $28,270.

The largest purchase of all time was on 2024-05-16 and amounted to 11000 shares of Abeona Therapeutics Inc. for $51,799.

The largest sale of all time was on 2021-05-07 and amounted to 8000 shares of PMV Pharmaceuticals, Inc. for $278,618.

Biography of Alland Leila

No biography is available at this moment.

2024-05-16PurchaseAbeona Therapeutics Inc.
ABEO
director
11,000
0.0286%
$4.71$51,799+18.07%
2023-09-27SaleAbeona Therapeutics Inc.
ABEO
director
7,246
0.0288%
$3.90$28,270+20.96%
2023-09-15SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
6,291
0.0128%
$6.62$41,646-73.47%
2021-09-09SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
100
0.0002%
$30.25$3,025-40.96%
2021-09-07SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
3,900
0.009%
$30.25$117,975-40.85%
2021-08-09SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
4,471
0.0095%
$34.04$152,202-46.87%
2021-07-07SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
4,000
0.0088%
$32.30$129,213-32.29%
2021-06-07SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
4,000
0.0089%
$33.60$134,387-30.42%
2021-05-07SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
8,000
0.0177%
$34.83$278,618-30.86%
2021-04-07SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
8,000
0.0178%
$33.86$270,889-19.47%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.